Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,652 | 126,263 | 52,251 | 86,943 | 55,592 |
| Marketable Securities | 43,709 | 26,012 | 59,195 | 114,923 | 193,545 |
| Receivables | 101 | 395 | 1,383 | 30,876 | 30,135 |
| Inventories | N/A | N/A | N/A | 3,989 | 4,147 |
| TOTAL | $145,416 | $157,719 | $121,938 | $246,192 | $291,614 |
| Non-Current Assets | |||||
| PPE Net | 296 | 295 | 11,106 | 11,524 | 13,582 |
| Intangibles | 44,543 | 44,543 | 44,543 | 63,376 | 63,818 |
| Other Non-Current Assets | 3,005 | 1,231 | 1,341 | 1,448 | 1,553 |
| TOTAL | $47,844 | $46,069 | $56,990 | $76,348 | $78,953 |
| Total Assets | $193,260 | $203,788 | $178,928 | $322,540 | $370,567 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,660 | 11,646 | 8,691 | 10,457 | 10,734 |
| Accounts payable and accrued liabilities | 4,926 | 5,469 | 11,734 | 29,763 | 18,236 |
| Accrued Expenses | 22,409 | 29,691 | 58,497 | 57,338 | 51,349 |
| TOTAL | $38,995 | $46,806 | $78,922 | $97,558 | $80,319 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 11,629 | 234,807 | 234,488 |
| Other Non-Current Liabilities | 1,718 | 611 | 738 | 862 | 983 |
| TOTAL | $1,718 | $611 | $12,367 | $235,669 | $235,471 |
| Total Liabilities | $40,713 | $47,417 | $91,289 | $333,227 | $315,790 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,388 | 144,354 | 117,475 | 107,106 | 106,970 |
| Common Shares | 145 | 142 | 117 | 108 | 108 |
| Retained earnings | -1,420,976 | -1,400,018 | -1,394,523 | -1,477,126 | -1,408,055 |
| Other shareholders' equity | 487 | 151 | 192 | 469 | 1,120 |
| TOTAL | $152,547 | $156,371 | $87,639 | $-10,687 | $54,777 |
| Total Liabilities And Equity | $193,260 | $203,788 | $178,928 | $322,540 | $370,567 |